Halozyme Therapeutics Inc and Chugai Pharmaceutical Enter Global Collaboration and License Agreement for ENHANZE
By, Admin1 min read
Share
Halozyme Therapeutics, Inc., announced a global collaboration and license agreement with Chugai Pharmaceutical Co., Ltd. that gives exclusive access to Halozyme's ENHANZE
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
